Prevalence of molecular markers of anti-malarial drug resistance in <it>Plasmodium vivax </it>and <it>Plasmodium falciparum </it>in two districts of Nepal
<p>Abstract</p> <p>Background</p> <p>Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have necessitated a change towards artemisinin combination therapy (ACT) ag...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/10/1/75 |